Work

OP022 Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: data from the CELEST study

Year: 2018

Type: conference-abstract

Source: Journal of Crohn s and Colitis

DOI: 10.1093/ecco-jcc/jjx180.021

Authors: S Schreiber, L Peyrin-Biroulet, B Boland, P D Higgins, A Armuzzi, J Terdiman, W Zhou, G Alperovich, F Cataldi, S Goteti, A P Lacerda

Institutions: University Hospital Schleswig-Holstein, Université de Lorraine, University of California San Diego, University of Michigan, Agostino Gemelli University Polyclinic, University of California, San Francisco, University of California San Francisco Medical Center, AbbVie (United States), AbbVie (Spain)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2793424877

Cites:

Cited by: 14

Related to: 10